For example, dna changes or other genetic changes may change the way the drug gets into the cancer cells or the way the drug is broken down. Dec 23, 2014 the book, while quite comprehensive, is not designed to, nor does it attempt to cover the entire field of drug resistance. Cancers have the ability to develop resistance to traditional therapies, and the increasing prevalence of these drug resistant cancers necessitates further research and treatment development. Data for protein expression and metabolic profiles are also being added. Definition of drug resistance nci dictionary of cancer. Overcoming drug resistance and treating advanced prostate cancer. Therapeutic resistance to antihormonal drugs in breast. An atpdependent drug efflux resistance phenotype without pgp overexpression was reported independently by two groups of investigators who selected hl60 human leukemia cells for resistance with. The text also discusses the cellular concomitants of multidrug resistance. Perhaps new terminology is needed for resistance that occurs following therapy with the targeted agents. The second edition of breast cancer metastasis and drug resistance brings together some of the.
The purpose of this book is to explore new concepts related to drug resistance in cancer, including resistance to the new molecularly targeted agents. The role of photodynamic therapy in overcoming cancer drug. Transforming cancer drug discovery with big data and ai. In cancer treatment, there are many things that may cause resistance to anticancer drugs. In some cases, cancers can evolve resistance to multiple drugs, called multiple drug resistance. Novel strategies to prevent the development of multidrug resistance. The term is used in the context of resistance that pathogens or cancers have acquired, that is, resistance has evolved. Overviews and methods contains chapters that cover topics such as. Using these resources, drug sensitivity can be correlated with cancer cell genomics, epigenomics and gene expression data, providing potential biomarkers of drug response see table 1 and reference 16. The book, while quite comprehensive, is not designed to, nor does it attempt to cover the entire field of drug resistance. Antineoplastic resistance, often used interchangeably with chemotherapy resistance, is the resistance of neoplastic cancerous cells, or the ability of cancer cells to survive and grow despite anticancer therapies. Read featured content on cancer research, treatment regimens and clinical studies.
The resistance of cancer cells to multiple chemotherapeutic agents prevents the success of therapy. This section is intended to introduce some of the main ways in which cancer cells can resist treatments. More than 30 years ago, they discovered that in some cases, when patients go from being sensitive to resistant to treatment, their cancer cells start to. Overview of resistance to systemic therapy in patients with breast. Current and emerging 3d models to study breast cancer. In order to combat resistance, chemotherapy drugs are often given in combination in the hopes that the cancer will fail to resist at least one of the drugs in the combination. In addition, accumulating evidence indicates that tumor cells can eject anticancer drugs such as chemotherapeutics and targeted drugs within evs, a novel mechanism of drug resistance. The second edition of breast cancer metastasis and drug resistance brings together some of the leading experts to comprehensively understand breast cancer. These cells have a selective advantage that allows them to overtake the population of tumor cells following cancer chemotherapy. Multidrug resistance is a mechanism by which chemotherapeutic drugs develops resistance in cancer treatment.
Drug resistance in cancer cells 2010, paperback for sale. Establishment of drugresistant xenograft tumor models in vivo. This paper outlines the current knowledge of mechanisms that promote or enable drug resistance, such as drug inactivation, drug target alteration, drug efflux, dna damage. Cancer drug resistance one of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells. Latest cancer articles, treatment info, research news and more for oncologists and medical professionals.
Drug resistance may be present before treatment is given or may occur during or after treatment with the drug. Abc transporters and multidrug resistance offers an essential resource for pharmaceutical researchers who are working to discover drugs to counteract multidrug resistance in diseases such as cancer. Cancer therapies are limited by the development of drug resistance, and mutations in drug targets is one of the main reasons for developing acquired resistance. Cancer cells can adapt and develop resistance to chemotherapy drugs, making it difficult to eradicate tumors. Cancer drug resistance cancer drug discovery and development. The evreleasing drug resistance phenotype is often coupled with cellular.
Novel mechanisms of drug resistance in leukemia leukemia. Editorial transforming cancer drug discovery with big data and ai paul workman a, albert a. Authoritative and insightful, cancer drug resistance offers basic and clinical investigators a stateoftheart synthesis of the many faceted research now. Once a cancer has developed resistance to one type of drug, it is. Micrornas, regulatory messengers inside and outside cancer cells. On the other hand, cyp1a1 and cyp1a2 metabolize procarcinogens into carcinogenic forms in the liver, and most anticancer drugs are metabolized by this method. Drug resistance is the reduction in effectiveness of a medication such as an antimicrobial or an antineoplastic in treating a disease or condition. Nielsen book data summary resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancerassociated mortality.
Cancer drug resistance overviews and methods jose rueff. Multiple mechanisms of drug resistance in cancer have been described, but typically involve efflux mechanisms and membrane associated changes to prevent drug accumulation within tumor, the acquisition of mutations which block drug action at the target, and cellular adaptation to drug treatment whereby the drug targeted pathway is bypassed. Resistance to chemotherapy and molecularly targeted therapies is a major problem facing current cancer research. Resistance can occur prior to drug treatment primary or innate resistance or may develop over time following exposure to. In one comprehensive volume, this book contains a collection of the most current knowledge on the involvement of abc transporters in drug transport. Brockman a former head of the drug resistance section of the southern research institute completed an approximately 100page book. Jun 07, 2019 scientists have discovered a small molecule drug that may stop cancer cells from becoming resistant to chemotherapy. Revamped drug may overcome resistance in brain tumours. Download progress in cancer drug resistance research pdf. Drug resistance in the treatment of cancer by herbert m. Bispecific and biparatopic antibody drug conjugates. Antimicrobial resistance and antineoplastic resistance challenge clinical care and drive research.
Cancer research uk scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults, according to research published in molecular cancer. Drug resistance is a major cause of cancer relapse and is responsible for as. Drug resistance is a wellknown phenomenon that results when diseases become tolerant to pharmaceutical treatments. Scientists have discovered a small molecule drug that may stop cancer cells from becoming resistant to chemotherapy. This book represents a timely publication in the filed of breast cancer research, providing current knowledge in the area of drug resistance and will be important reading material for clinicians and researchers alike. This volume discusses the latest advancements and technologies used in cancer drug resistance research. Among the different metabolic and signalling pathways that are altered in cancer cells, variations in the expression and activity of several drug metabolizing enzymes play a critical role in drug resistance rochat, 2009. Unfortunately, novel drug development by cell and molecular biologists, often.
Jun 15, 2009 abc transporters and multidrug resistance offers an essential resource for pharmaceutical researchers who are working to discover drugs to counteract multidrug resistance in diseases such as cancer. Cancer drug design and discovery, second edition is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. It is conceivable that resistance induced by one treatment might be overcome by another treatment. A molecular glue to overcome cancer drug resistance. Chapters cover topics of current clinical concern, including multiple drug resistance and its reversal, topoisomerase drugs, apoptosis, dose intensity and escalation, gene therapy and haematopoietic support. Overcoming drug resistance and treating advanced prostate. Cancer drug resistance is an open access journal, focusing on pharmacological aspects of drug resistance and its reversal, molecular mechanisms of drug. Antolin a,band bissan allazikani athe cancer research uk cancer therapeutics unit, the institute of cancer research, london, uk. In figure 1, a schematic overview of potential resistance mechanisms is given. Molecular mechanisms and therapeutic strategies, volume 8 1st edition.
Breast cancer metastasis and drug resistance challenges. Abc transporters and multidrug resistance wiley online books. Drug resistance is the most important cause of anticancer treatment failure for both chemotherapy and targeted therapy. One of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells.
This concept was first considered when bacteria became resistant to certain antibiotics, but since then similar mechanisms have been found to occur in other diseases, including cancer. The book describes the colon cancer as a model for resistance to antineoplastic drugs. Multidrug resistance mdr is the most essential test to compelling chemotherapeutic. Authoritative and insightful, cancer drug resistance offers basic and clinical investigators a stateoftheart synthesis of the many faceted research now available on the biology and genetics of tumor resistance, as well as exciting new approaches to its prevention and eradication. Recent drug resistance updates articles recently published articles from drug resistance updates. Circumventing cancer drug resistance in the era of. Breast cancer metastasis and drug resistance challenges and. Even though the process of drug design has become exceedingly sophisticated in recent years, there is not a single drug available that is 100% effective against metastatic cancer. Tumors may either be intrinsically drug resistant or develop resistance to anticancer drugs during treatment. Resistance to treatment with anticancer drugs results from a variety of factors including individual variations in patients and somaticgenetic differences in tumors. This work addresses the resistance of solid tumors to anticancer therapeutics by considering mechanisms that involve alterations in genetics and epigenetics, cellular biochemistry, and properties related to physiology of solid tumor mass. The journal focuses on pharmacological aspects of drug resistance and its reversal, including drug design, drug delivery, drug distribution and cellular drug resistance, etc. The conventional perception of drug resistance suggests that a minority of cells in the tumor acquire genetic changes that confer drug resistance. Sep 24, 20 drug resistance group, centre for cancer research and cell biology, queens university belfast, 97 lisburn road, belfast, bt9 7bl, uk caitriona holohan, sandra van schaeybroeck.
This is a very serious problem that may lead to recurrence of disease or even death. Helps in understanding the complex interactions between host, tumor and cytotoxic or immunomodulatory agents. Novel combination of drugs may overcome drugresistant cancer cells. In cancer drug resistance, leading scientists from the best academic institutions and industrial laboratories summarize and synthesize the latest discoveries concerning the changes that occur in tumor cells as they develop resistance to a. This work addresses the resistance of solid tumors to anticancer therapeutics by. Once a cancer has developed resistance to one type of drug, it is more likely to develop resistance to other drugs, making treatment more difficult. Those are the conventional and the cancer stemcell theories. Drug combinations to overcome treatment resistance. Drug combinations to overcome treatment resistance national. Systemic treatment of breast cancer includes cytotoxic, hormonal, and. More than 30 years ago, they discovered that in some. Mechanisms of drug resistance in neoplastic cells sciencedirect. Combating and overcoming drug resistance in cancer frontiers. New chapters have been added to this edition on areas of particular interest and therapeutic promise, including cancer genomics and personalized medicine, dna.
350 451 183 972 1353 292 722 1188 533 708 1133 942 1122 1366 260 139 1023 1527 1627 754 78 1051 239 1277 33 1548 694 989 1276 394 219 5 361 1202 937 1395 602 1123 305 85 660 874 165 960 367